158 related articles for article (PubMed ID: 26968770)
1. Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy.
Birket SE; Chu KK; Houser GH; Liu L; Fernandez CM; Solomon GM; Lin V; Shastry S; Mazur M; Sloane PA; Hanes J; Grizzle WE; Sorscher EJ; Tearney GJ; Rowe SM
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L928-39. PubMed ID: 26968770
[TBL] [Abstract][Full Text] [Related]
2. Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR.
Birket SE; Davis JM; Fernandez-Petty CM; Henderson AG; Oden AM; Tang L; Wen H; Hong J; Fu L; Chambers A; Fields A; Zhao G; Tearney GJ; Sorscher EJ; Rowe SM
Am J Respir Crit Care Med; 2020 Nov; 202(9):1271-1282. PubMed ID: 32584141
[No Abstract] [Full Text] [Related]
3. The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements.
Char JE; Dunn C; Davies Z; Milla C; Moss RB; Wine JJ
PLoS One; 2017; 12(4):e0175486. PubMed ID: 28419121
[TBL] [Abstract][Full Text] [Related]
4. 1-BENZYLSPIRO[PIPERIDINE-4,1'-PYRIDO[3,4-b]indole] 'co-potentiators' for minimal function CFTR mutants.
Son JH; Phuan PW; Zhu JS; Lipman E; Cheung A; Tsui KY; Tantillo DJ; Verkman AS; Haggie PM; Kurth MJ
Eur J Med Chem; 2021 Jan; 209():112888. PubMed ID: 33092904
[TBL] [Abstract][Full Text] [Related]
5. Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways.
Cho DY; Zhang S; Skinner D; Koch CG; Smith MJ; Lim DJ; Grayson JW; Tearney GJ; Rowe SM; Woodworth BA
J Cyst Fibros; 2023 Nov; 22(6):1113-1119. PubMed ID: 37704464
[TBL] [Abstract][Full Text] [Related]
6. Glutathione and bicarbonate nanoparticles improve mucociliary transport in cystic fibrosis epithelia.
Cho DY; Rivers NJ; Lim DJ; Zhang S; Skinner D; Yang L; Menon AJ; Kelly OJ; Jones MP; Bicknell BT; Grayson JW; Harris E; Rowe SM; Woodworth BA
Int Forum Allergy Rhinol; 2023 Nov; ():. PubMed ID: 37975554
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced cystic fibrosis transmembrane conductance regulator dysfunction is a universal mechanism underlying reduced mucociliary transport in sinusitis.
Cho DY; Zhang S; Norwood TG; Skinner D; Hollis TA; Ehrhardt ML; Yang LC; Lim DJ; Grayson JW; Lazrak A; Matalon S; Rowe SM; Woodworth BA
Int Forum Allergy Rhinol; 2023 Dec; ():. PubMed ID: 38073611
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.
Carrasco-Hernández L; Quintana-Gallego E; Calero C; Reinoso-Arija R; Ruiz-Duque B; López-Campos JL
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680554
[TBL] [Abstract][Full Text] [Related]
9. Co-cultured microfluidic model of the airway optimized for microscopy and micro-optical coherence tomography imaging.
Liu Z; Mackay S; Gordon DM; Anderson JD; Haithcock DW; Garson CJ; Tearney GJ; Solomon GM; Pant K; Prabhakarpandian B; Rowe SM; Guimbellot JS
Biomed Opt Express; 2019 Oct; 10(10):5414-5430. PubMed ID: 31646055
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel.
Pesce E; Gorrieri G; Sirci F; Napolitano F; Carrella D; Caci E; Tomati V; Zegarra-Moran O; di Bernardo D; Galietta LJ
J Cyst Fibros; 2016 Jul; 15(4):425-35. PubMed ID: 26971626
[TBL] [Abstract][Full Text] [Related]
11. Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis.
Esposito S; Tosco A; Villella VR; Raia V; Kroemer G; Maiuri L
Mol Cell Pediatr; 2016 Dec; 3(1):13. PubMed ID: 26976279
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.
Reihill JA; Walker B; Hamilton RA; Ferguson TE; Elborn JS; Stutts MJ; Harvey BJ; Saint-Criq V; Hendrick SM; Martin SL
Am J Respir Crit Care Med; 2016 Sep; 194(6):701-10. PubMed ID: 27014936
[TBL] [Abstract][Full Text] [Related]
13. Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.
Meijer L; Nelson DJ; Riazanski V; Gabdoulkhakova AG; Hery-Arnaud G; Le Berre R; Loaëc N; Oumata N; Galons H; Nowak E; Gueganton L; Dorothée G; Prochazkova M; Hall B; Kulkarni AB; Gray RD; Rossi AG; Witko-Sarsat V; Norez C; Becq F; Ravel D; Mottier D; Rault G
J Innate Immun; 2016; 8(4):330-49. PubMed ID: 26987072
[TBL] [Abstract][Full Text] [Related]
14. New and emerging targeted therapies for cystic fibrosis.
Quon BS; Rowe SM
BMJ; 2016 Mar; 352():i859. PubMed ID: 27030675
[TBL] [Abstract][Full Text] [Related]
15. Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators.
Wang W; Hong JS; Rab A; Sorscher EJ; Kirk KL
PLoS One; 2016; 11(3):e0152232. PubMed ID: 27007499
[TBL] [Abstract][Full Text] [Related]
16. Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations.
Vermeulen F; Le Camus C; Davies JC; Bilton D; Milenković D; De Boeck K
J Cyst Fibros; 2017 Jan; 16(1):36-40. PubMed ID: 26996268
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers.
Hou Y; Guan X; Yang Z; Li C
World J Gastrointest Oncol; 2016 Mar; 8(3):282-8. PubMed ID: 26989463
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.
Locke LW; Myerburg MM; Weiner DJ; Markovetz MR; Parker RS; Muthukrishnan A; Weber L; Czachowski MR; Lacy RT; Pilewski JM; Corcoran TE
Eur Respir J; 2016 May; 47(5):1392-401. PubMed ID: 27009167
[TBL] [Abstract][Full Text] [Related]
19. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.
Iannitti RG; Napolioni V; Oikonomou V; De Luca A; Galosi C; Pariano M; Massi-Benedetti C; Borghi M; Puccetti M; Lucidi V; Colombo C; Fiscarelli E; Lass-Flörl C; Majo F; Cariani L; Russo M; Porcaro L; Ricciotti G; Ellemunter H; Ratclif L; De Benedictis FM; Talesa VN; Dinarello CA; van de Veerdonk FL; Romani L
Nat Commun; 2016 Mar; 7():10791. PubMed ID: 26972847
[TBL] [Abstract][Full Text] [Related]
20. New drug developments in the management of cystic fibrosis lung disease.
Turnbull AR; Davies JC
Expert Opin Pharmacother; 2016 Jun; 17(8):1103-12. PubMed ID: 27017976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
